The level of expression of HPV16 early transcripts is not associated with the natural history of cervical lesions

被引:2
作者
Jacquin, Elise [1 ,8 ]
Saunier, Maelle [1 ]
Lepiller, Quentin [1 ,2 ,4 ]
Monnien, Franck [3 ]
Mauny, Frederic [4 ]
Ramanah, Rajeev [5 ,6 ]
Carcopino, Xavier [7 ]
Riethmuller, Didier [1 ,9 ]
Mougin, Christiane [1 ,2 ,10 ]
Pretet, Jean-Luc [1 ,2 ]
机构
[1] Univ Franche Comte, EA3181, Besancon, France
[2] CHU Besancon, Ctr Natl Reference Papillomavirus, Besancon, France
[3] CHU Besancon, Tumorotheque Reg Franche Comte, Besancon, France
[4] Univ Franche Comte, CNRS, CHRONO E UMR 6249, Besancon, France
[5] Univ Franche Comte, SINERGIES, Besancon, France
[6] CHU Besancon, Serv Gynecol Obstet, Besancon, France
[7] Univ Aix Marseille, Hop Nord, APHM, Dept Gynecol Obstet, Marseille, France
[8] Univ Bourgogne, Ctr Translat & Mol Med, INSERM, UMR 1231, Dijon, France
[9] CHU Grenoble, Serv Gynecol Obstet, Grenoble, France
[10] Univ Franche Comte, EFS, INSERM, RIGHT,UMR 1098, Besancon, France
关键词
cervical cancer; early transcript; HPV; quantification; HUMAN-PAPILLOMAVIRUS TYPE-16; VIRAL-DNA LOAD; LIQUID-BASED CYTOLOGY; MESSENGER-RNA; RESIDUAL MATERIAL; PHYSICAL STATE; E2/E6; RATIO; LOW-GRADE; WOMEN; CANCER;
D O I
10.1002/jmv.29875
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The natural history of cervical cancer is closely linked to that of high-risk human papillomaviruses (HPV) infection. It is recognized that upon HPV DNA integration, partial or complete loss of the E2 open reading frame precludes expression of the corresponding protein, resulting in upregulation of the E6 and E7 viral oncoproteins. To better characterize HPV16 infection at the cervical level, viral load, viral DNA integration, and viral early transcript expression (E2, E5, and E6) were analyzed in a series of 158 cervical specimens representative of the full spectrum of cervical disease. Overall, the frequency of early transcript detection varied from 45% to 90% and tended to increase with lesion severity. In addition, the levels of E2, E5, and E6 transcript expression were slightly higher in high-grade lesions than in cervical specimens without abnormalities. Notably, early transcript expression was clearly associated with viral load, and no inverse correlation was found between the expression of E2 and E6 transcripts. No clear association was found between early transcript expression and HPV16 DNA integration, with the exception that samples with a fully integrated HPV16 genome did not harbor E2 or E5 transcripts. In conclusion, early HPV16 transcript expression appears to be associated with viral load rather than lesion grade. From a practical point of view, quantification of HPV16 early transcripts is difficult to translate into a relevant biomarker for cervical cancer screening.
引用
收藏
页数:10
相关论文
共 55 条
[11]   Significance of HPV 16 and 18 viral load quantitation in women referred for colposcopy [J].
Carcopino, Xavier ;
Henry, Mireille ;
Mancini, Julien ;
Giusiano, Sophie ;
Boubli, Leon ;
Olive, Daniel ;
Tamalet, Catherine .
JOURNAL OF MEDICAL VIROLOGY, 2012, 84 (02) :306-313
[12]   A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical precancer and cancer [J].
Castle, Philip E. ;
Dockter, Janel ;
Giachetti, Cristina ;
Garcia, Francisco A. R. ;
McCormick, Mary Kay ;
Mitchell, Amy L. ;
Holladay, E. Blair ;
Kolk, Daniel P. .
CLINICAL CANCER RESEARCH, 2007, 13 (09) :2599-2605
[13]   Quantification of intracellular HPV E6/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA [J].
Coquillard, Gerald ;
Palao, Biniana ;
Patterson, Bruce K. .
GYNECOLOGIC ONCOLOGY, 2011, 120 (01) :89-93
[14]   Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions [J].
Cricca, Monica ;
Morselli-Labate, Antonio Maria ;
Venturoli, Simona ;
Ambretti, Simone ;
Gentilomi, Giovanna Angela ;
Gallinella, Giorgio ;
Costa, Silvano ;
Musiani, Monica ;
Zerbini, Marialuisa .
GYNECOLOGIC ONCOLOGY, 2007, 106 (03) :549-557
[15]   Worldwide burden of cancer attributable to HPV by site, country and HPV type [J].
de Martel, Catherine ;
Plummer, Martyn ;
Vignat, Jerome ;
Franceschi, Silvia .
INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (04) :664-670
[16]   A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs [J].
Demarco, Maria ;
Hyun, Noorie ;
Carter-Pokras, Olivia ;
Raine-Bennett, Tina R. ;
Cheung, Li ;
Chen, Xiaojian ;
Hammer, Anne ;
Campos, Nicole ;
Kinney, Walter ;
Gage, Julia C. ;
Befano, Brian ;
Perkins, Rebecca B. ;
He, Xin ;
Dallal, Cher ;
Chen, Jie ;
Poitras, Nancy ;
Mayrand, Marie-Helene ;
Coutlee, Francois ;
Burk, Robert D. ;
Lorey, Thomas ;
Castle, Philip E. ;
Wentzensen, Nicolas ;
Schiffman, Mark .
ECLINICALMEDICINE, 2020, 22
[17]   Changes in type-specific human papillomavirus load predict progression to cervical cancer [J].
Depuydt, Christophe E. ;
Criel, Arnold M. ;
Benoy, Ina H. ;
Arbyn, Marc ;
Vereecken, Annie J. ;
Bogers, Johannes J. .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2012, 16 (12) :3096-3104
[18]   Spatiotemporally deciphering the mysterious mechanism of persistent HPV-induced malignant transition and immune remodelling from HPV-infected normal cervix, precancer to cervical cancer: Integrating single-cell RNA-sequencing and spatial transcriptome [J].
Guo, Chenyan ;
Qu, Xinyu ;
Tang, Xiaoyan ;
Song, Yu ;
Wang, Jue ;
Hua, Keqin ;
Qiu, Junjun .
CLINICAL AND TRANSLATIONAL MEDICINE, 2023, 13 (03)
[19]   Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts [J].
Hafner, N. ;
Driesch, C. ;
Gajda, M. ;
Jansen, L. ;
Kirchmayr, R. ;
Runnebaum, I. B. ;
Duerst, M. .
ONCOGENE, 2008, 27 (11) :1610-1617
[20]   Type-specific human papillomavirus oncogene messenger RNA levels correlate with the severity of cervical neoplasia [J].
Ho, Chih-Ming ;
Lee, Bor-Heng ;
Chang, Shwu-Fen ;
Chien, Tsai-Yen ;
Huang, Shih-Hung ;
Yan, Chiu-Cho ;
Cheng, Wen-Fang .
INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (03) :622-632